Arcturus Therape Stock Price, News & Analysis
ARCT
NASDAQ
Company Description
Welcome to the overview page for Arcturus Therape (ARCT), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$152,310,000
Revenue (TTM)
-$80,941,000
Net Income (TTM)
-$3.00
-$59,747,000
Operating Cash Flow
-53.14%
-62.81%
Upcoming Events
JAN
01
January 1, 2026 - June 30, 2026
Clinical
12-week safety/efficacy study
12-week safety and preliminary efficacy study enrolling up to 20 participants
JAN
01
January 1, 2026 - June 30, 2026
Clinical
Phase 2 CF study start
12-week, up-to-20-participant ARCT-032 Phase 2 CF study planned H1 2026
JAN
01
January 1, 2026 - June 30, 2026
Clinical
ARCT-810 Phase 3 planning
Initiation of Phase 3 planning for OTC deficiency therapy ARCT-810 in H1 2026
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Arcturus Therape (ARCT)?
The current stock price of Arcturus Therape (ARCT) is $6.13 as of December 31, 2025.
What is the market cap of Arcturus Therape (ARCT)?
The market cap of Arcturus Therape (ARCT) is approximately 175.9M. Learn more about what market capitalization means .
What is the revenue (TTM) of Arcturus Therape (ARCT) stock?
The trailing twelve months (TTM) revenue of Arcturus Therape (ARCT) is $152,310,000.
What is the net income of Arcturus Therape (ARCT)?
The trailing twelve months (TTM) net income of Arcturus Therape (ARCT) is -$80,941,000.
What is the earnings per share (EPS) of Arcturus Therape (ARCT)?
The diluted earnings per share (EPS) of Arcturus Therape (ARCT) is -$3.00 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Arcturus Therape (ARCT)?
The operating cash flow of Arcturus Therape (ARCT) is -$59,747,000. Learn about cash flow.
What is the profit margin of Arcturus Therape (ARCT)?
The net profit margin of Arcturus Therape (ARCT) is -53.14%. Learn about profit margins.
What is the operating margin of Arcturus Therape (ARCT)?
The operating profit margin of Arcturus Therape (ARCT) is -62.81%. Learn about operating margins.
What is the current ratio of Arcturus Therape (ARCT)?
The current ratio of Arcturus Therape (ARCT) is 4.67, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Arcturus Therape (ARCT)?
The operating income of Arcturus Therape (ARCT) is -$95,669,000. Learn about operating income.